TGFβ2-induced senescence during early inner ear development by Gibaja, Alejandro et al.
1Scientific RepoRts |          (2019) 9:5912  | https://doi.org/10.1038/s41598-019-42040-0
www.nature.com/scientificreports
tGFβ2-induced senescence during 
early inner ear development
Alejandro Gibaja1, María R. Aburto1, Sara Pulido1,2, Manuel Collado  3, Juan M. Hurle4, 
Isabel Varela-Nieto1,2,5 & Marta Magariños1,2,6
Embryonic development requires the coordinated regulation of apoptosis, survival, autophagy, 
proliferation and differentiation programs. Senescence has recently joined the cellular processes 
required to master development, in addition to its well-described roles in cancer and ageing. Here, 
we show that senescent cells are present in a highly regulated temporal pattern in the developing 
vertebrate inner ear, first, surrounding the otic pore and, later, in the otocyst at the endolymphatic 
duct. Cellular senescence is associated with areas of increased apoptosis and reduced proliferation 
consistent with the induction of the process when the endolymphatic duct is being formed. Modulation 
of senescence disrupts otic vesicle morphology. Transforming growth factor beta (TGFβ) signaling 
interacts with signaling pathways elicited by insulin-like growth factor type 1 (IGF-1) to jointly 
coordinate cellular dynamics required for morphogenesis and differentiation. Taken together, these 
results show that senescence is a natural occurring process essential for early inner ear development.
The vertebrate inner ear is the organ that senses sound, movement and position. Most of the cell types that pop-
ulate the adult vestibular and auditory parts of the inner ear have a common developmental origin in the otic 
placode1. These cell types include sensory hair cells, supporting cells, secretory cells and neurons for the vestibu-
lar and acoustic ganglia, all spatially organized with a fine-tuned geometry matched for the functions of hearing 
and equilibrium2. The developmental processes that give rise to such precise structure involve cell differentiation 
and morphogenetic events. Once otic identity is established in the neuroectoderm, the otic placode invaginates 
to form the otic cup, which closes up giving rise to the otic vesicle. The acoustic-vestibular ganglion neurons 
specify at the ventral part of the otic cup and vesicle, neuroblasts delaminate and migrate towards the neural 
tube3. In parallel, the otic vesicle cells undergo proliferation, apoptosis and differentiation. Cellular dynamics 
underlie morphogenetic movements that generate the primordium of the different sensory receptors, as well 
as the endolymphatic duct and other structures of the adult inner ear. Apoptosis is crucial for the closure of the 
otic pore, shaping the otic vesicle, the migration of the epithelial neuroblasts and for adjusting the numbers of 
adult neurons4,5. The efficient removal of these damaged or unnecessary cells requires energy that is provided by 
autophagy6.
Factors secreted by otic and neighbouring cells participate in regional morphogenesis establishing the dor-
soventral axis of the otic vesicle. WNT and bone morphogenetic protein (BMP) signalling are involved in the 
determination of the dorsal vestibular region responsible for balance perception, whereas sonic hedgehog (SHH) 
signalling is required for specification of the ventral auditory region7.
Cell senescence is defined as a stable cell-cycle arrest elicited in response to damage, such as intense onco-
genic signalling, DNA damage and telomere loss8. Senescent cells express inhibitors of cyclin dependent 
kinases, as p21, p15 and p16, whereas the expression of cell cycle-promoting genes is suppressed. Senescent 
cells also show increased expression of the lysosomal β-galactosidase enzyme, a feature manifested as 
stronger senescence-associated β-galactosidase staining (SAβG), and present a secretory profile known as 
the senescence-associated secretory phenotype (SASP) that include soluble factors that modulate the cellular 
microenvironment9. Senescence has been classically considered a tumour suppressor mechanism and also a sign 
of aging10,11. More recently it has been shown that cellular senescence is a developmental program involved in the 
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remodelling or elimination of the endolymphatic sac, the mesonephros, the neural tube, the apical ectodermal 
ridge (AER) and the interdigital tissue12–14. Developmental senescence acts together with apoptosis in the elimi-
nation of unwanted cells as well as in patterning and morphogenesis14. It shares most of the cellular characteristics 
of oncogene-induced senescence, such as arrested proliferation, increased SAβG staining and a secretory pheno-
type. But not all the mediators, only p21 plays an important role in mammalian developmental senescence12,13. In 
the chicken embryo, the tumour suppressor genes Btg1 and Btg2 are associated with developmental senescence14.
Extrinsic factors and intracellular signalling regulate cellular senescence in a tissue-specific manner. In the 
mouse endolymphatic duct, the activation of the phosphoinositide 3-kinase (PI3K)/FOXO pathway is a neg-
ative regulator of developmental cell senescence, whereas TGFβ/SMAD is an inductor12. In the mouse AER, 
the RAF-MEK-ERK pathway instructs senescence in neighbouring mesenchymal cells13. Interestingly, senescent 
cells secrete TGFβ, IGFBPs and cytokines among other pro-inflammatory, anti-proliferative and pro-apoptotic 
signals15.
Insulin-like growth factor 1 (IGF-1) belongs to the insulin family of peptides and it is a potent pro-survival 
factor for epithelial and neuronal otic populations via the activation of the PI3K/AKT pathway16,17. IGF-1 also 
activates the RAF-MEK-ERK cascade to promote the proliferation of otic progenitors18,19. IGF-1 and its recep-
tor IGF1R are expressed during vertebrate otic development20, where IGF-1 is essential for the differentiation 
and survival of mouse auditory neurons21. Moreover, IGF-1 deficiency is a rare human disease associated with 
syndromic deafness22. On the other hand, TGFβ superfamily includes BMPs, TGFβs, activins and nodal, which 
bind to type I and II receptors (TGFRI and TGFRII) forming the active tetrameric receptors23. Cytoplasmic pro-
teins are then recruited and phosphorylated by the active receptor. Typically receptor-activated SMAD proteins 
(R-SMAD) form heteromeric complexes with the common mediator SMADs (Co-SMAD). R-SMAD/Co-SMAD 
complexes translocate to the nucleus and regulate the expression of target genes. BMPs and TGFβ bind different 
TGFβ receptors and activate different SMAD proteins24, showing distinct downstream signalling traits. Further 
modulation is exerted by additional cell surface receptors like TGFβR3 that also modulates the cellular response 
to TGFβ223, as well as transmembrane proteins, like endoglin, that associate with receptors to further modulate 
their activity25. The role of BMP ligands has been extensively studied in the otic vesicle26,27, however, the role of 
TGFβ2 has not been investigated to date.
Here, we show the presence of cellular senescence during early otic development of the chicken embryo. 
Positive senescent cells in the developing inner ear show temporal and regional-specific patterns. Cells of the 
endolymphatic duct show intense senescence associated with apoptosis and reduced proliferation. We also 
observed that both navitoclax elimination of senescent otic cells and palbociclib induction of senescence disrupt 
the morphology of the otocyst. Distinct expression patterns of TGFβ factors and receptors as well as regulation 
of downstream mediators supported the key role of the TGFβ superfamily during otic early development. Thus, 
TGFβ2 promotes senescence in the developing inner ear, whilst its inhibition abolishes SMAD2 phosphorylation 
and reduces TGFβ2-induced SAβG. Further studies on coregulatory mechanisms showed the participation of 
RAF-MEK-ERK and the PI3K/AKT pathways in the modulation of otic developmental senescence.
Material and Methods
Chicken and mouse embryos. Chicken embryos were obtained from fertilized eggs from a local farm 
(Granja Santa Isabel, Cordoba, Spain) and they were incubated in a humidified atmosphere at 37.8 °C. Embryos 
were staged according to Hamburger and Hamilton’s (HH) criteria28. Mouse embryos were obtained from 
C57BL/6J mice that were purchased from Charles River (Barcelona, Spain) and housed under standard condi-
tions. All experiments were approved by the CSIC Bioethics Committee and carried out in full accordance with 
the guidelines of the European Community (2010/63/EU) and the Spanish regulations (RD 53/2013).
Embryo and tissue preparation for in situ hybridization and immunofluorescence. Whole 
embryos or tissues were dissected in phosphate-buffered saline (PBS) and fixed overnight in 4% (w/v) paraformal-
dehyde (PFA; Merck, Darmstadt, Germany) in PBS at 4 °C. Subsequently, embryos were cryoprotected overnight 
in 15% sucrose/PBS at 4 °C and then embedded at 37 °C in 15% sucrose/10% gelatine in PBS. Gelatine-embedded 
tissues were frozen in isopentane at −80 °C and sectioned (20 μm) at −25 °C in a cryostat (Cryocut 1900; Leica 
Microsystems, Deerfield, IL). The sections obtained were used for in situ hybridization or immunofluorescent 
staining as described6,17,19.
Isolation, organotypic culture and treatment of otic vesicles. Embryos at stage HH18 (65 h of 
incubation) were obtained and the otic vesicles were dissected from the surrounding mesenchymal tissue with 
sharpened tungsten needles, they were transferred into four-well culture-plates (Nunc Roskilde, Denmark) and 
then incubated at 37 °C in a water-saturated atmosphere containing 5% CO2. The standard culture medium was 
M199 medium with Earle’s salts (Sigma Aldrich Química, Madrid, Spain) supplemented with 2 mM glutamine 
(Gibco, Paisley, UK) and antibiotics [50 IU/ml penicillin (Ern, Barcelona, Spain) and 50 mg/ml streptomycin 
(CEPA, Madrid, Spain)]. For immunostaining and TUNEL labelling otic vesicles were fixed for 2 h in PFA at 4 °C. 
For SAβG staining the otic vesicles were fixed for 10 min with the fixative solution provided by the Senescence 
β-Galactosidase Staining Kit (Cell Signaling Technology, Danvers, Massachusetts, USA).
Ex vivo cultures were performed as previously reported6,16,17,19. Explants were treated with either the BCL-2/
BCL-XL-inhibitor navitoclax (1 µM, ABT263, Selleckchem, Houston, TX, USA), the CDK4/CDK6 inhibitor pal-
bociclib (1 µM, PD0332991, Selleckchem), BOC (200 µM, Boc-D-fluoromethyl ketone, Calbiochem, La Jolla, CA, 
USA), TGFβ2 (10 ng/ml, PeproTech, Rocky Hill, NJ, USA), the TGFβR1 inhibitor SB431542 (10 µM, Sigma), 
IGF-1 (10 nM, recombinant IGF-1, Roche Molecular Biochemicals, Basel, Switzerland), sorafenib (2.5 µM, BAY 
43–9006, Bayer HealthCare Pharmaceuticals, West Haven, CT, USA), or AKTi (50 µM, AKT inhibitor VIII, 
Calbiochem). The concentrations used did not show toxicity nor did the 0.01% dimethyl sulfoxide (DMSO) 
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solvent. Otic vesicle explants cultured in serum-free medium without additives were used as experimental con-
trols (0S).
Endolymphatic duct and dorsal areas were measured from light microscopy images using the FIJI package 
image processing based on ImageJ software (Wayne Rasband, National Institutes of Health, Bethesda, MD). 
Results are presented as the mean ± SEM of the percentage of the area of interest per total otic vesicle area. Values 
were normalized to the 0S explants.
Quantitative RT-PCR. Otic vesicles were dissected out from chicken embryos and pooled to obtain RNA 
at different developmental stages: closure of the otic cup (HH17, n = 45–50), formation and growth of the otic 
vesicle (HH18, n = 30–40), endolymphatic duct emergence (HH19, n = 25–30) and a more differentiated stage 
(HH23, n = 5–10). Microdissection of HH19 otic explants was performed to isolate dorsal and ventral regions. 
Three to four independent pools of RNA from each stage were isolated with TRIZOL (Invitrogen, Carlsbad, 
CA) following the manufacturer’s instructions. The integrity and concentration of the RNA was assessed with an 
Agilent Bioanalyzer 2100 (Agilent Technologies) and cDNA was generated by reverse transcription, RT, (High 
Capacity cDNA Reverse Transcription Kit; Applied Biosystems). Quantitative PCR (qPCR) of each pool was 
performed in triplicate using specific oligonucleotides for the indicated genes. Specific primers for chicken genes 
would be provided upon request. Eukaryotic 18S rRNA and HPRT1 were used as endogenous housekeeping 
genes. SYBR Green qPCR was performed on a 7900HT Real-Time PCR System and gene expression was esti-
mated as 2−ΔΔCt.
Immunohistochemistry and immunofluorescence. Antibodies used for immunofluorescence are 
shown in Supplementary Information Table S1. Procedures used have been described elsewhere6,17,19. Levels of 
PH3 immunostaining and otic vesicle areas were quantified using FIJI software, in compiled confocal microscopy 
projections as reported17,19. Colour channels of the signals of interest were converted into grey scale images. 
Subsequently both the area and the intensity of the signal were measured, and normalized to the 0S condi-
tion, which was given an arbitrary value of 100. 3–6 samples per condition were assayed from 2–6 independent 
experiments.
Western blotting. Otic vesicles (HH18, n = 25) were isolated and cultured for 20 h for protein extraction 
and analysis as reported17,19. Membranes were incubated overnight at 4 °C, with the primary antibodies indicated 
in Supplementary Information Table S1. Images of the blots were captured using an ImageQuant LAS4000 mini 
digital camera (GE Healthcare Bio-Sciences), and densities of the immunoreactive bands were quantified by den-
sitometry using ImageQuant TL software (GE Healthcare Bio-Sciences).
Apoptosis. Apoptotic cell death patterns were studied by Tdt-mediated dUTP nick-end labelling (TUNEL) of 
fragmented DNA using the kit Dead-EndTM Fluorometric TUNEL System (Promega, Madison, WI) as described 
by the manufacturer in frozen sections as reported5, or adapted to whole organ labelling6,17,19. Otic vesicles were 
mounted in Prolong Gold/DAPI and visualized by confocal microscopy. TUNEL-positive nuclei were quantified 
from compiled confocal microscopy projections by FIJI software and the results are presented as the mean ± SEM 
of the positive cells per total area. Values were normalized to those of the 0S explants.
Senescence-associated beta-galactosidase staining. SAβG was performed by using the Senescence 
β-Galactosidase Staining Kit (Cell Signaling Technology). After culture and fixation, otic vesicles were washed in 
PBS and incubated with the X-Gal solution at pH 6 at 37 °C protected from light. For SAβG in whole embryos at 
stages HH17, HH18, HH19 and HH20, the embryos were fixed for 15 min and incubated in X-Gal solution. To 
perform the SAβG in chicken embryo tissue sections, the embryos were obtained, fixed for 15 min, frozen and 
sectioned. Sections were post-fixed for 2 min and incubated with the X-Gal solution.
EdU labelling and SAβG staining of otic vesicles. Otic vesicles (HH18) were isolated and cultured for 
20 h. EdU (5-ethynyl-2′-deoxyuridine, Invitrogen) was diluted in PBS-DMSO 1% and added for the last hour of 
the culture at a final concentration of 100 µM. Otic vesicles were fixed for 20 min and incubated with the X-Gal 
solution pH 6 at 37 °C. Then, otic vesicles were fixed with PFA, permeabilized with PBS-T, washed with 2% 
PBS-BSA and incubated with the Click-iT Reaction Cocktail (Invitrogen) with Alexa-488 or Alexa Fluor 594 
(5 µM, Invitrogen) at RT in darkness for 30 min. Finally, they were washed again with 2% PBS-BSA and mounted 
in Vectashield with DAPI (Vector, Peterborough, UK).
SAβG staining levels and EdU labelling were quantified using the FIJI image processing software based on 
ImageJ. The colour channels of the signals of interest were converted into grey scale images. The blue staining area 
was analysed relative to the otic vesicle total area. Levels of EdU signal from compiled confocal microscopy were 
measured and relativized to otic vesicle total area. Data were normalized to the 0S condition, which was given an 
arbitrary value of 100.
In situ hybridization. In situ hybridization with digoxigenin-labelled antisense RNA probes (1 mg/ml) 
was performed essentially as described previously with minor modifications17. Three HH18, HH20 and HH25 
embryos were tested for Tgfβ2 and three HH18 embryos were tested for Tgfβr2 expression in at least two inde-
pendent experiments. Specificity of the signal was assessed by hybridization of a sense riboprobe29.
Statistics. Results are shown as mean ± SEM and the statistical significance was determined with the 
Student’s t-test. A p < 0.05 was considered significant. *p < 0.05; **p < 0.01; ***p < 0.001.
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Figure 1. Senescence in the developing chicken inner ear. SAβG staining in the otic epithelium of chicken 
embryos at HH17 (A) and at HH20 (B) stages showing intense staining in the otic pore and in the developing 
endolymphatic duct (arrows). (C) Representative microphotograph of an otic vesicle cryosection SAβG stained. 
(D–E) SAβG staining in isolated otic vesicles from E10 mouse (D) and HH18 chicken (E) embryos showing 
specific labelling at the endolymphatic duct. (F) p21, Btg1 and Btg2 mRNA expression levels were measured by 
RT-qPCR in HH18 (white bars) and HH19 (black bars) otic vesicle explants. Gene expression was calculated 
as 2−ΔΔCt and normalized to the levels at HH18. The results are expressed as the means ± SEM from three 
independent experiments performed in triplicate. Statistical significance was determined with the Student’s 
t-test: **P < 0.01, ***P < 0.005, versus HH18. (G–I) SAβG staining associated to the endolymphatic duct 
throughout early morphological changes in an otocyst ex vivo culture. Otic vesicles were isolated from HH18 
chicken embryos and cultured for 24, 48 and 72 h in free-serum medium (0S). (J) Proliferation was evaluated 
by EdU incorporation (red) at HH18 otic vesicles cultured ex vivo for 20 h. (K) TUNEL labelling (green) in 
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Ethical standards. The experiments comply with the current laws of the countries in which they were 
performed.
Results
Cellular senescence during early development of the inner ear. β-galactosidase staining (SAβG) 
was used to study the presence of senescent cells in the developing inner ear in whole-mount HH17 to HH20 
embryos (Supplementary Information Fig. S1). HH17 embryos showed marked staining of SAβG in the otic 
epithelium, with the highest levels observed around the otic pore (Fig. 1A), an area of known intense apopto-
sis30. Later in development (HH19-HH20), SAβG staining was intense in the endolymphatic duct (Fig. 1B,C). 
Dissected otic vesicles from mouse E10 and HH19 chicken embryos showed that senescence is highly restricted 
to the developing endolymphatic duct in both species (Fig. 1D,E), suggesting that otic senescence is dynamic and 
developmentally-regulated. To assess the time-window of otic senescence induction, expression levels of p21, Btg1 
and Btg2 were analysed by RT-qPCR in HH18 (white bars) and HH19 (black bars) otic vesicle explants. While 
p21 expression was not significantly increased, Btg1 and Btg2 showed a significant increase (2.7-fold and 2-fold 
respectively) in HH19 compared to HH18 (Fig. 1F).
Isolated HH18 otic vesicles were cultured for 24, 48 and 72 h and the intense SAβG staining at the endo-
lymphatic duct showed that senescence could be studied ex vivo (Fig. 1G–I, arrows). Endolymphatic duct 
SAβG-labelled senescent cells did not show EdU incorporation (Fig. 1J, arrow), thus, increased senescence was 
associated with reduced proliferation. Finally, TUNEL assay confirmed the presence of increased apoptosis in the 
endolymphatic duct (Fig. 1K, arrow). Figure 1L schematizes otocysts patterns of the above described senescent, 
apoptotic and proliferative cells. Taken together, these data suggest that developmental senescence contributes to 
sculpt the otocyst.
Otic morphological changes are associated with modulation of senescence. Otic vesicles were 
next incubated with navitoclax that specifically promotes apoptosis of senescent cells31. Navitoclax-treated otic 
vesicles showed a 70% reduction of SAβG staining (Fig. 2A,E, quantification in M), a rounded morphology 
and a reduction in the endolymphatic duct area (0.8-fold, Fig. 2B,F, asterisk, quantification in N). EdU incor-
poration and immunofluorescence for mitotic cells with PH3 showed an increment of cells in the S-phase in 
navitoclax-treated otic vesicles (1.3-fold, Fig. 2C,D,G,H, quantification in P-Q). The elimination of senes-
cent cells with navitoclax also increased the number of apoptotic cells (Supplementary Information Fig. S2). 
Conversely, reduction of apoptosis by treatment with the pan-caspase inhibitor BOC increased SAβG staining 
(Supplementary Information Fig. S2). These results suggest a link between apoptosis and senescence during 
endolymphatic duct formation.
To promote senescence, explants were treated with palbociclib32. After 20 h in culture, palbociclib treatment 
promoted a 2.9-fold increment of SAβG staining (Fig. 2A,I, quantification in M) in otic vesicles showing an 
expanded and thinned dorsal region (Fig. 2B,J, insets, quantification in O). Induction of senescence with palbo-
ciclib was associated with the absence of proliferation markers (Fig. 2C,D,K,L, quantification in P-Q). To further 
document navitoclax and palbociclib actions, we examined gene expression levels of p21, Btg1 and Btg2, which 
were upregulated by palbociclib (1.52-, 1.57- and 1.48-fold respectively; Fig. 2R). Finally, considering that it has 
been reported that the highly secretory senescent cells require induction of autophagy to restore cell homeosta-
sis33, we measured Lc3b (microtubule-associated protein light chain 3 beta, widely used as an autophagy biomarker) 
transcription levels that indeed were increased in otic vesicles incubated with palbociclib (1.38-fold; Fig. 2R).
In summary, we show that otic vesicle morphogenesis can be modulated by drugs that increase or reduce 
cellular senescence, which particularly impact the formation of the endolymphatic duct.
tGFβ family factors and their receptors are expressed in the developing inner ear. Senescent 
cells have a secretory phenotype that is essential to modify their cellular microenvironment, with TGFβ family 
members featuring among the secreted factors15. To explore the mediator that induces senescence in the endo-
lymphatic duct, we considered the actions of TGFβ/BMP signalling with a special interest in TGFβ2, a factor that 
has not been explored in this context before.
The expression of Tgfβ2, Tgfβ3, Tgfβr1, Tgfβr2, Tgfβr3 and Eng was studied by RT-qPCR in inner ear extracts 
from HH17-HH19 and HH23 embryonic stages (Fig. 3A). All the analysed transcripts were expressed in the stud-
ied stages, but with distinct temporal patterns. Tgfβr1 and Tgfβr3 expression levels did not vary, but, in contrast, 
Tgfβ2, Tgfβ3 and the receptor Tgfβr2 transcripts showed a significant increase at HH23, whereas the co-receptor 
Eng increased its expression at stage HH19 that persisted to HH23. These data were further confirmed as the 
expression of TFGβ-system genes in HH23 inner ear explants was associated with areas of increased SAβG stain-
ing (data not shown).
The cellular expression pattern of the transcript for Tgfβ2 was further studied by in situ hybridization 
(Fig. 3B,C). Tgfβ2 mRNA presented a localized expression at stage HH18 in the endolymphatic duct precursor 
area (Fig. 3B first panel, arrow). Consistent with TGFβ2 signalling, we found typical nuclear immunopositivity 
for the phosphorylated SMAD2 effector protein (pSMAD2) in the otic epithelium of the otic vesicle and in the 
endolymphatic duct anlagen (Fig. 3B, third panel). Tgfβr2 was found to be strongly expressed in the dorsal part 
embryo sections showed the presence of apoptotic cells in the developing endolymphatic duct. (L) Drawing 
summarizing the localization of senescent, apoptotic and proliferative cells in the otic vesicle. Abbreviations: Ed, 
endolymphatic duct; OC, otic cup; OP, otic pore; OV, otic vesicle. Orientation: A, anterior; D, dorsal. Scale bar: 
80 μm. Representative microphotographs are shown from at least n = 5 otic vesicles per condition.
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Figure 2. Senescence modulation disrupts early inner ear development. Otic vesicles were isolated from HH18 
chicken embryos and cultured ex vivo for 20 h in serum free medium (0S) (A–D), in the presence of navitoclax 
(1 µM, E–H) or palbociclib (1 µM, I–L). SAβG staining in the otic epithelium of chicken embryos reveals the 
modulation of senescence levels (A,E,I), quantification in (M) data are represented as SAβG mean area ± SEM 
with respect to the otic vesicle area, normalized to the 0S condition. The statistical significance was determined 
by Student’s t-test: **P < 0.01, ***P < 0.005 versus control condition (0S, white bars). Light microscopy 
images are shown to visualise morphology (B,F,J). Navitoclax-treated otic vesicles showed reduction of the 
endolymphatic duct area (F, asterisk, quantification in N); note the expanded and thinned otocyst dorsal region 
caused by the palbociclib treatment in comparison with the control condition (B,J, insets; quantifications in O). 
Proliferation was measured by EdU incorporation (red; C,G,K, quantification in P) and by immunostaining 
for the mitotic marker phospho-Histone-3, PH3 (red; D,H,L, quantification in Q). Representative images from 
optical or compiled confocal microscopy are shown from at least six otic vesicles per condition studied, in at 
least three independent experiments. Quantification for areas and inmunostainings were measured as described 
in Materials and Methods. Data are shown as the mean ± SEM and the statistical significance was determined by 
Student’s t-test: *P < 0.05, **P < 0.01, ***P < 0.005 versus control condition (0S, white bars). Scale bar, 150 µm. 
(R) p21, Btg1, Btg2 and Lc3b mRNA expression levels were measured by RT-qPCR in isolated HH18 otic vesicles 
cultured for 20 h. Gene expression was calculated as 2−ΔΔCt and normalized to the levels of the control condition 
(0S, white bars). The results are expressed as the mean ± SEM from three independent experiments performed 
in triplicate. Statistical significance was determined with the Student’s t-test: *P < 0.05, ***P < 0.005, versus 0S. 
Ed, endolymphatic duct; Orientation: A, anterior; D, dorsal.
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Figure 3. TGFβ pathway expression in the inner ear during early development. (A) Expression of Tgfβ2, 
Tgfβ3, Tgfβr1, Tgfβr2, Tgfβr3 and Eng mRNA in the inner ear was measured by RT-qPCR at the indicated 
developmental stages. Eukaryotic 18s rRNA was used as an endogenous control gene. Gene expression was 
calculated as 2−ΔΔCt and normalized to the HH17 levels. The results are expressed as mean ± SEM from 
four independent experiments. (B) TGFβ pathway components (Tgfβ2, Tgfβr2 and pSMAD2) expression 
in inner ear sections. At HH18 Tgfβ2 was expressed in the dorsal area of the otic epithelium, where the 
endolymphatic duct will emerge (first panel, arrow). Tgfβr2 was expressed predominantly in the dorsal area of 
the otic epithelium, including the endolymphatic duct anlagen (second panel, arrow). The presence of active 
TGFβ signalling was assessed with immunodetection of the phosphorylated downstream effector protein 
SMAD2 (pSMAD2), which showed a nuclear localization throughout the otic epithelium and the developing 
endolymphatic duct (third panel, arrow). (C) Tgfβ2 was strongly expressed in the developing endolymphatic 
duct at later developmental stages, HH20 and HH25 (arrows). Representative microphotographs are shown 
from at least three embryos per condition. Orientation: A, anterior; D, dorsal; L, lateral; M, medial; R, rostral. 
Scale bars: 100 μm.
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of the otic epithelium, which includes the endolymphatic duct anlagen (Fig. 3B, second panel, arrow). We also 
investigated the presence of Tgfβ2 at later developmental stages and found strong expression in the developing 
endolymphatic duct at stages HH20 and HH25 (Fig. 3C, arrows).
Thus, our results show that the TGFβ signalling is active in the otic epithelium during early inner ear develop-
ment, with specific expression of TGFβ2 in the endolymphatic duct area.
tGFβ2 promotes senescence in the otic vesicle. Otic vesicles (HH18) were isolated and cultured with 
or without exogenous TGFβ2 (Fig. 4). TGFβ2 significantly increased SAβG by 2-fold (Fig. 4A,B, quantification in 
F) and increased Btg1 and Btg2 expression levels (1.18-fold and 1.33-fold respectively; Fig. 4G). To further con-
firm the role of TGFβ2 in the regulation of otic senescence, otic vesicle explants were treated with the inhibitor 
of TGFβ signalling SB43154234. TGFβ2-induced SMAD2 phosphorylation was reduced by co-treatment with 
Figure 4. TGFβ pathway induction of senescence in the otocyst. (A–D) SAβG staining in isolated otic vesicles 
from stage HH18 embryos cultured ex vivo for 20 h in free serum medium (0S), in the presence of TGFβ2 
(10 ng/ml), SB (SB431542; 10 µM) or a combination of both. (E) Levels of pSMAD2 were measured by western 
blotting of explanted otic vesicle lysates (two independent experiments). (F) SAβG staining quantification is 
shown as mean SAβG area ± SEM with respect to the total area, normalized to the 0S condition (white bar). 
***p < 0.001 vs 0S; #p < 0.05 vs SB. (G) Btg1 and Btg2 mRNA expression levels were measured by RT-qPCR in 
cultured otic vesicles. Statistical significance was determined with the Student’s t-test: ***P < 0.005, versus 0S. 
(H) Wnt2b mRNA expression levels were measured by RT-qPCR in non-cultured HH18 and HH19 otic vesicles 
and in dissected dorsal and ventral regions from HH19 otic vesicles. Statistical significance was determined 
with the Student’s t-test: ***P < 0.005, versus HH18; ###P < 0.005, versus HH19 dorsal regions. (I,J) Light 
microscopy images from TGFβ2-treated otic vesicles showing the relative increment of the endolymphatic duct 
area (J, asterisk, quantification in K). Quantification for areas were measured and are shown as the mean ± SEM 
and the statistical significance was determined by Student’s t-test: *P < 0.05, versus control condition (0S, white 
bars). (L) Wnt2b mRNA levels were measured by RT-qPCR in cultured otic vesicles in 0S medium, in presence 
of TGFβ2 (10 ng/ml) or palbociclib (1 µM). Statistical significance was determined with the Student’s t-test: 
***P < 0.005, versus 0S. Gene expression was calculated as 2−ΔΔCt and normalized to the levels of 0S (white 
bars). The results are expressed as the mean ± SEM (three independent experiments performed in triplicate). 
Ed, endolymphatic duct. Orientation: A, anterior; D, dorsal. Scale bar: 150 μm.
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SB431542 (Fig. 4E), and SB431542 also reduced TGFβ2-induced SAβG staining (Fig. 4C,D, quantification in F). 
In contrast, SAβG staining in the control condition (0S) was not modified by SB431542.
To explore if TGFβ2 modulates endolymphatic duct morphogenesis we analysed the morphology of the oto-
cyst as well as the expression levels of Wnt2b, which is specifically expressed in the mouse endolymphatic duct35. 
We confirmed that Wnt2b is expressed in the chicken endolymphatic duct by showing its upregulation (1.47-fold) 
in HH19 otic vesicle explants. Concordantly, Wnt2b expression was higher (7.3-fold) in dissected dorsal regions 
of HH19 otic explants compared to ventral regions (Fig. 4H). In parallel, the ventral-expressed Neurog1 was 
downregulated in HH19 (0.52-fold) consistently with its role in early neurogenesis3 and the expression levels were 
upregulated (2-fold) in the ventral region compared to the dorsal region (Supplementary Information Fig. S3). 
The association between cellular senescence and endolymphatic duct development was further confirmed by the 
differentiation of the endolymphatic duct observed following TGFβ2 treatment (Fig. 4I,J, asterisk, quantification 
in K). This was consistent with the significant increase of Wnt2b found in otic vesicles treated with either TGFβ2 
(3-fold) or palbociclib (1.47-fold; Fig. 4L). Therefore, we conclude that TGFβ2 plays an inductive role in endo-
lymphatic duct morphogenesis by promoting cellular senescence.
PI3K/AKT and RAF-MEK-ERK pathways modulate senescence in the otic vesicle. Based on pre-
vious findings from our lab17,19, IGF-1 was used as an activator of otic PI3K/AKT and RAF-MEK-ERK path-
ways. Figure 5 shows a significant decrease (70%) of SAβG staining in the presence of the RAF kinase inhibitor 
sorafenib (Fig. 5A,B, quantification in H), whereas an increase was observed when the activity of AKT was inhib-
ited (7.7-fold; Fig. 5A,C, quantification in H). Treatment with AKTi or sorafenib inhibited the phosphorylation 
of AKT and ERK, respectively (Fig. 5G). To further understand the interplay between the extrinsic factors that 
regulate these pathways, cellular senescence was studied following IGF-1-stimulation (Fig. 5D–F). SAβG staining 
was increased by IGF-1 (1.9-fold), which was able to partially overcome the effects of sorafenib but not those of 
AKTi that were even potentiated (Fig. 5E,F quantification in 5 H). In contrast, palbociclib-induced senescence 
showed reduced Igf1 transcript levels (0.52-fold; Fig. 5I) but increased Igf1r expression (1.37-fold). These results 
are in agreement with the arrested proliferative status of senescent cells (Figs 1J and 2Q,R) and the reported pro-
liferative role of IGF-136. Upregulation of IGF1R transcription is a typical compensatory cell response to reduced 
IGF-1 signalling37,38.
Discussion
Here we show that senescence plays a role in the early development of the endolymphatic duct, site of intense 
programmed cell death and reduced proliferation. Elimination of senescent cells and induction of senescence in 
the otic vesicles showed opposing morphogenetic defects. Our results show that senescence is induced by TGFβ2 
in the otic vesicle, where TGFβ pathway components are expressed at these early embryonic stages. In addition, 
IGF-1 targeted kinases AKT and RAF modulated SAβG staining in the otic vesicle.
Developmental senescence in the otic vesicle is confirmed by specific SAβG staining, arrested proliferation 
and senescence related gene transcript upregulation. Btg1 and Btg2 appeared to be particularly relevant as senes-
cence read-outs in chicken. Both genes are differentially regulated in limb samples of species that eliminate the 
interdigital tissue by senescence (chicken) compared to those that doesn´t (duck). Btg1 and Btg2 are both upregu-
lated during interdigital tissue regression (7.5–8d) in chick limbs, while in the duck limbs Btg1 is upregulated but 
Btg2 is downregulated14. Our results show that Btg1 and Btg2 expression is modulated during otic development, 
being both upregulated at HH19 at the time of endolymphatic duct formation. Btg1 and Btg2 roles in senescence 
was further confirmed by their induction with palbociclib and TGFβ2.
Senescence is very intense at the edges of the pores of structures that arise from ectoderm invaginations which 
eventually close up, such as the otic pore and the lens vesicle pore. Apoptosis is also present at pore edges during 
the otic cup stage, which associates with the folding and subsequent closure and separation of the otic vesicle 
from the ectoderm4. These results suggest a connection between senescence and apoptosis in promoting the 
closure of the otic cup to form the otocyst. The concurrence of senescence and apoptosis during development has 
been recently demonstrated in the vertebrate limb, particularly in the AER and the elimination of the interdigital 
tissue13,14. Our work also shows that senescence staining and TUNEL labelling coincides in specific areas of the 
endolymphatic duct also showing signs of cell cycle arrest. Therefore, our data support the presence of develop-
mental senescence concomitant with reported areas of apoptosis in the otocyst4.
Research on senescence during development published to date shows that underlying molecular mecha-
nisms and function vary depending on the structure. Developmental senescence in the interdigital webs of the 
developing limb is followed by apoptosis and subsequently removed by macrophage-mediated phagocytosis14. 
Mesonephros elimination is due to senescent cells that are also subsequently removed by macrophage-mediated 
phagocytosis12. This cell-clearing function might be conserved in all vertebrates studied from teleost fish to 
mice39. Thus, senescence might be a conserved mechanism that facilitates the elimination of the excess of cells 
generated during development.
Work from us and others show developmental senescence at regions that undergo morphological changes and 
generate three-dimensional structures such as the dorsal region of the pharyngeal slits, the edges of the optic lens 
vesicle pores, the pineal gland and the otic vesicle13. Moreover, senescence has been reported to be a remodel-
ling mechanism in Xenopus laevis cement gland40. The morphological changes that the HH18 otocyst undergoes 
include the protrusion of the endolymphatic duct. Elimination of senescent cells abolished endolymphatic duct 
morphogenesis. It would therefore be reasonable to propose here that senescence facilitates the acquisition of the 
three-dimensional otic vesicle shape, first by blocking proliferation and second by promoting the slow removal 
of cells.
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Figure 5. IGF-1 modulates developmental senescence of chicken inner ear. (A–F) SAβG staining in isolated 
otic vesicles from stage HH18 embryos cultured ex vivo for 20 h in free serum medium (0S), in the presence 
of IGF-1 (10 nM), Sor (2.5 µM), AKTi (50 μM) or a combination. (G) Phosphorylation state of IGF-1 targets 
in HH18 otic vesicles explanted and incubated with the indicated treatments. pERK, pAKT and AKT were 
measured by western blotting of at least n = 15 otic vesicle lysates in two independent experiments. To improve 
the clarity of the presentation lanes have been grouped. Full-length blots are presented in Supplementary 
Figure S3. (H) SAβG staining quantification by FIJI software. Data are shown as mean SAβG area ± SEM 
with respect to the otic vesicle area, normalized to the 0S condition. *p < 0.05, ***p < 0.001 vs 0S; #p < 0.05, 
###p < 0.001 vs. indicated inhibitor. (I) Igf1 and Igf1r mRNA levels from explanted HH18 otic vesicles in the 
absence (0S, white bars) or presence of palbociclib (1 µM). Gene expression was calculated as 2−ΔΔCt and 
normalized to the levels of the control condition (0S). The results are expressed as the means ± SEM from three 
independent experiments performed in triplicate. Statistical significance was determined with the Student’s 
t-test: ***P < 0.005, versus 0S. Ed, endolymphatic duct. Orientation: A, anterior; D, dorsal. Scale bar: 150 μm.
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Our results also suggest a role for developmental senescence in otic dorso-ventral patterning. The phenotype 
of otic vesicles treated with palbociclib showed a dorsalized otocyst with increased SAβG staining in the ventral 
region. This result might be explained by the ectopic secretion in the ventral region of SASP component(s) that 
could promote dorsalization. In fact, the palbociclib-induced phenotype is related to that of the effect of BMP4 
overexpression which also induces thinning and ventral expansion of the dorsal epithelium41.
Later in development, senescence facilitates the maturation of the endolymphatic sac by favouring the pres-
ence of pendrin-positive cells12, which are essential for the maintenance of the endolymph in the adult inner ear42. 
Thus, senescence during the developing inner ear plays different roles sequentially, first sculpting the endolym-
phatic duct in the otocyst and later defining endolymphatic sac cell populations.
TGFβ2 plays an inductive role in programmed senescence during mouse embryonic development12. Our data 
show that TGFβ2 also promotes senescence during inner ear development. Tgfβ2 is expressed in the otic epithe-
lium with the highest levels observed in the dorsal part of the otocyst, including the endolymphatic duct anlagen. 
Its target pSMAD2 was also present in these areas. In our hands, TGFβ2-treatment potentiates endolymphatic 
duct formation through senescence. These results are particularly interesting because inhibition of BMP-ligands 
reduces differentiation of dorsal otic areas without affecting endolymphatic duct formation41. Therefore, our work 
proposes a specific role for TGFβ2 on the endolymphatic duct morphogenesis by means of inducing senescence. 
The specific expression of TGFβ2 in the endolymphatic duct at HH18 and HH20 reinforce the proposed actions 
for TGFβ2 in the formation of the endolymphatic duct. Further supporting this view is the fact that TGFβ2 defi-
cient mice show morphological defects and alterations in the homeostasis of endolymph43.
Surprisingly, in the absence of an exogenous source of TGFβ2, blocking endogenous TGFβ signalling with 
SB431542 does not suffice to decrease otic senescence. This highlights the fact that the inhibitor may not be com-
pletely inhibiting its target, TGFβR1. The small reduction in the magnitude of the phenotype upon addition of 
both SB431542 and TGFβ2 might explain why we do not observe a significant reduction in the senescence with 
the inhibitor alone as compared to the control condition (0S).
However, we cannot exclude that other senescence-modulating players could be playing a role in compensat-
ing the absence of complete TGFβ signaling. One strong candidate might be IGF-1.
Our results showed that palbociclib inhibited cell proliferation and reduced Igf1 expression. IGF-1 is a crucial 
survival and proliferation factor for otic precursors in a variety of species from chicken to mammals16,44. IGF-1 
actions in the developing inner ear are mainly mediated by the RAF-MEK-ERK cascade and the PI3K/AKT path-
way17,19. Inhibition of PI3K/AKT increased senescence in the otocyst, suggesting that this pathway is repressing 
senescence as reported during mouse development12. On the contrary, the inhibition of RAF kinases by sorafenib 
reduces senescence, suggesting that this pathway promotes both proliferation and senescence. Accordingly, Storer 
et al., 2013 showed the non-autonomous involvement of the RAF-MEK-ERK pathway in the induction of devel-
opmental senescence in the mouse AER. These data suggest that senescence could be one of the mechanisms 
activated secondarily to proliferation to control the extent of cell division needed to sculpt the otocyst. B-RAF 
expression shows a highly specific pattern in the chicken developing inner ear that is very intense in the endo-
lymphatic duct19, thus our data also suggest that the degree of activation of RAF kinases might be the trigger that 
switches cell fate from proliferation to senescence. Accordingly, it has been reported that increased B-RAF activity 
may correlate with cell cycle arrest and the expression of typical cell senescence markers45.
IGF-1 is a survival factor whose proliferative actions have been well-documented36. Our data show that 
IGF-1 induced proliferation and survival but also an increase in the number of cell cycle-arrested senescent cells. 
Therefore, our data suggest that as a consequence of IGF-1 strong induction of proliferation there is an immediate 
induction of senescence to sculpt the otocyst in those areas where a more active remodelling is needed, as in the 
endolymphatic duct. Indeed, IGF-1 treatment during 24 h turns a rounded otic vesicle into a pear-shaped struc-
ture with the primordium of the endolymphatic duct evidenced at the most dorsal region46. The fact that IGF-1, 
IGF1R and B-RAF are expressed at the endolymphatic duct during chicken otic development16,19, is consistent 
with this hypothesis.
In summary, our work shows that cellular senescence occurs in the developing inner ear. TGFβ2 is a potent 
inductor of senescence that may be instructing endolymphatic duct morphogenesis. We also show here that cell 
proliferation induced by IGF-1 via activation of RAF kinases modulates developmental senescence and, in turn, 
morphogenetic events.
Data Availability
The datasets generated during and/or analysed during the current study are available from the corresponding 
author on reasonable request.
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